Inhalable curcumin formulations by supercritical technology

Inhalable dry formulations for pulmonary delivery of curcumin have been produced by supercritical antisolvent micronization. The antioxidant curcumin was co-processed with hydroxypropyl-beta-cyclodextrin (HP-ß-CD) and polyvinylpyrrolidone (PVP) to form binary and ternary composites with enhanced flo...

Full description

Bibliographic Details
Main Authors: Kurniawansyah, F., Mammucari, R., Foster, Neil
Format: Journal Article
Published: Elsevier 2015
Online Access:http://hdl.handle.net/20.500.11937/19028
_version_ 1848749916243886080
author Kurniawansyah, F.
Mammucari, R.
Foster, Neil
author_facet Kurniawansyah, F.
Mammucari, R.
Foster, Neil
author_sort Kurniawansyah, F.
building Curtin Institutional Repository
collection Online Access
description Inhalable dry formulations for pulmonary delivery of curcumin have been produced by supercritical antisolvent micronization. The antioxidant curcumin was co-processed with hydroxypropyl-beta-cyclodextrin (HP-ß-CD) and polyvinylpyrrolidone (PVP) to form binary and ternary composites with enhanced flow-ability for pulmonary delivery. The micronization process adopted was the atomized rapid injection solvent extraction (ARISE) system, and was operated at 95 bar and at temperatures of 25 °C and 40 °C. The products were evaluated in terms of morphology, composition, crystallinity and aerodynamic particle size distributions. A synergistic effect of the excipients on the aerodynamic properties of micronized curcumin formulations has been found. The fine particle fraction (FPF) of curcumin in ARISE-processed powders was as high as 61% in ternary systems, whilst untreated curcumin had a FPF of 10% and micronized binary systems had FPF below 40%. The process produced yields of about 80%, demonstrating significant potential for further development of curcumin formulations for pulmonary administration.
first_indexed 2025-11-14T07:28:32Z
format Journal Article
id curtin-20.500.11937-19028
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T07:28:32Z
publishDate 2015
publisher Elsevier
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-190282017-09-13T13:44:33Z Inhalable curcumin formulations by supercritical technology Kurniawansyah, F. Mammucari, R. Foster, Neil Inhalable dry formulations for pulmonary delivery of curcumin have been produced by supercritical antisolvent micronization. The antioxidant curcumin was co-processed with hydroxypropyl-beta-cyclodextrin (HP-ß-CD) and polyvinylpyrrolidone (PVP) to form binary and ternary composites with enhanced flow-ability for pulmonary delivery. The micronization process adopted was the atomized rapid injection solvent extraction (ARISE) system, and was operated at 95 bar and at temperatures of 25 °C and 40 °C. The products were evaluated in terms of morphology, composition, crystallinity and aerodynamic particle size distributions. A synergistic effect of the excipients on the aerodynamic properties of micronized curcumin formulations has been found. The fine particle fraction (FPF) of curcumin in ARISE-processed powders was as high as 61% in ternary systems, whilst untreated curcumin had a FPF of 10% and micronized binary systems had FPF below 40%. The process produced yields of about 80%, demonstrating significant potential for further development of curcumin formulations for pulmonary administration. 2015 Journal Article http://hdl.handle.net/20.500.11937/19028 10.1016/j.powtec.2015.04.083 Elsevier restricted
spellingShingle Kurniawansyah, F.
Mammucari, R.
Foster, Neil
Inhalable curcumin formulations by supercritical technology
title Inhalable curcumin formulations by supercritical technology
title_full Inhalable curcumin formulations by supercritical technology
title_fullStr Inhalable curcumin formulations by supercritical technology
title_full_unstemmed Inhalable curcumin formulations by supercritical technology
title_short Inhalable curcumin formulations by supercritical technology
title_sort inhalable curcumin formulations by supercritical technology
url http://hdl.handle.net/20.500.11937/19028